US · Healthcare · Health Information Services
EPS came in at -0.21 against a street estimate of -0.24 — a beat of 12.5%.
Analysts rate Teladoc Inc a hold (5 buy, 19 hold, 0 sell out of 24) with an average price target of $7.67.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.04% |
| Vanguard Portfolio Management, LLC | 6.77% |
| Renaissance Technologies Corp | 4.45% |
| Voss Capital LLC | 4.43% |
| Vanguard Capital Management, LLC | 4.32% |
| Point72 Asset Management, L.P. | 4.25% |
| Dimensional Fund Advisors, Inc. | 4.06% |
| American Century Companies Inc | 2.69% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 TELADOC HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Michael Grasher hired as Chief Financial Officer, effective August 31, 2026 • Annual base | 2026-08-31 |
| Board / officer change · Q3 2026 TELADOC HEALTH, INC. – FORM 8-K SUMMARY OTHER NOTABLE POINTS • Board Member Departure: David B. Snow, Jr. notified the company on August 10, 2026 of | 2026-08-13 |
| Board / officer change · Q3 2026 TELADOC HEALTH, INC. - FORM 8-K SUMMARY Filed August 3, 2026 --- BUSINESS & SEGMENT HIGHLIGHTS • Teladoc Health appointed Mark V. Anquillare as a n | 2026-08-03 |
| Quarterly report · Q2 2026 TELADOC HEALTH, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue (Q2 2026): $606.9 million vs. $631.9 million (Q2 2025) — decline of 4.0 | 2026-07-30 |
| Results announced · Q3 2026 TELADOC HEALTH INC. - Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 revenue: $606.9 million, down 4% year-over-year • Q2 2026 net loss: $38.9 m | 2026-07-29 |
| Quarterly report · Q1 2026 TELADOC HEALTH, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $613.8 million (down 2.5% year-over-year from $629.4 million in Q1 2 | 2026-04-30 |
| Proxy statement · Q2 2026 TELADOC HEALTH, INC. — 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect nine director nominees for one-year terms (m | 2026-04-07 |
| Annual report FY2025 TELADOC HEALTH, INC. — 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company completed 17.1 million telehealth visits in 2025 • Approximately | 2026-02-26 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Teladoc Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.